The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China

NCT04228393 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia, Pediatric

Interventions

DRUG: 6-mercaptopurine
PROCEDURE: Standard treatment
PROCEDURE: Individualized treatment

Sponsor

Wei Zhao

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]